Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT07409272
A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ASP3082 in Combination with mFOLFIRINOX or NALIRIFOX as First-line Treatment in Participants with KRAS G12D mutated Metastatic Pancreatic Adenocarcinoma
Status
Open
Conditions
Pancreas
Phases
3 (Cancer Control)
Age Group
Adult
Main Investiagtor
Zaiden, Robert
Practice
GI
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT07409272
Secondary Trial ID Number
3082-CL-0301
Keywords
Treatment